Home
Database Statistics
Help System
About
Literature
Projects
Events
Login / Register
A modified reversed-phase high-performance liquid chromatographic method for the determination of plasma sulphasalazine concentrations.
1988
C Astbury
Clinical Pharmacology Unit, Royal Bath Hospital, Harrogate, North Yorkshire HG1 2PS, UK.
Associated MeSH Terms
Cite
UI
MeSH Term
Description
Entries
Related Publications
C Astbury
A reversed phase high performance liquid chromatographic method for determination of rapamycin.
January 2013, Iranian journal of pharmaceutical research : IJPR,
C Astbury
A reversed-phase high-performance liquid chromatographic method for the determination of Clanfenur in rat and human plasma.
July 1994, Journal of pharmaceutical and biomedical analysis,
C Astbury
[Reversed-phase high performance liquid chromatographic determination of propofol in human plasma].
July 1997, Se pu = Chinese journal of chromatography,
C Astbury
Reversed-phase high-performance liquid chromatographic determination of gliclazide in human plasma.
January 1980, Chemical & pharmaceutical bulletin,
C Astbury
Reversed-phase high-performance liquid chromatographic determination of taxol in mouse plasma.
May 1994, Journal of chromatography. B, Biomedical applications,
C Astbury
Reversed-phase high-performance liquid chromatographic determination of salbutamol in rabbit plasma.
February 1984, Journal of chromatography,
C Astbury
Reversed-phase high performance liquid chromatographic determination of nifedipine in human plasma.
January 1985, Therapeutic drug monitoring,
C Astbury
[Determination of alpha-methoxynaphthalene by reversed-phase high performance liquid chromatographic method].
May 1999, Se pu = Chinese journal of chromatography,
C Astbury
A rapid reversed phase high performance liquid chromatographic method for determination of etoposide (VP-16) in human plasma.
June 2001, Journal of pharmaceutical and biomedical analysis,
C Astbury
A reversed-phase high-performance liquid chromatographic method for the determination of zafirlukast in pharmaceutical formulations and human plasma.
January 2006, Journal of AOAC International,
Export Citation
×
Select Citation Style to be generated
APA
Vancouver
Harvard
BibTeX
Endnote
Generated Citation:
Selection Actions
Export Citations
Download Data
Save To My Collection
Need Help?
Explore features, get started with a guided tour, or view relevant help articles.
Start Tour
Go to Related Help Article
Copied contents to your clipboard!
Publications over Time
×
Save Item To Your Collection
×
Collection Name
Your saved publications will be grouped by this name - think of it like a folder to group related publications and results.
Use default name